Famotidine Powder, For Suspension
Product Images NDC 68180-150
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 68180-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
93d01e19 749c 4f2e Bbdc E3eda54a9dca 02
Famotidine for Oral Suspension is a medication that contains 300 mg of famotidine per 5 mL of reconstituted suspension. The usual adult dosage is indicated in the accompanying prescribing information. To reconstitute, 46 mL of water should be added to the bottle, which should then be shaken vigorously for 5-10 seconds. The reconstituted solution should be kept in a tight container protected from light at a temperature of 25°C (77°F) with excursions permitted to 15° to 30°C (59° to 86°F). The manufacturer is Lupin Limited in India, and the medication is distributed by Lupin Pharmaceuticals, Inc. in Baltimore, MD.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.